Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Mid-Term Amputation Free Survival After Lower Extremity Bypass for Peripheral Arterial Disease.

Isaac N Naazie,Isibor Arhuidese,Mohammad S Abdelgawwad,Jonathan Unkart,Michael S Conte,Mahmoud B Malas

Annals of vascular surgery（2022）

引用 0|浏览14

暂无评分

摘要

Isolated preoperative RAASI use was associated with worse 30-day mortality and 2-year AFS while continuous RAASI use was associated with improved 30-day mortality and 2-year AFS. Optimum survival benefit may be derived from continuous RAAS inhibition in the pre- and postoperative periods.

查看译文

关键词

Angiotensin converting enzyme inhibitor,amputation free survival,limb revascularization,lower extremity bypass,peripheral arterial disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要